Role of muscarinic M1 receptors in inhibitory avoidance and contextual fear conditioning

Neurobiology of Learning and Memory

Volumn 86, Issue 2, 2006, Pages 188-196

  Soares, Juliana Carlota Kramer ^a   Fornari, Raquel Vecchio ^a   Oliveira, Maria Gabriela Menezes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cholinergic; Dicyclomine; Fear conditioning; Inhibitory avoidance; M1 muscarinic receptor

Indexed keywords

DICYCLOVERINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TESTING ALTERNATIVE; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; CONDITIONING; CONTROLLED STUDY; DISSOCIATION; DRUG SCREENING; FEAR; MALE; NEUROCHEMISTRY; NONHUMAN; RAT; STATISTICAL ANALYSIS; TASK PERFORMANCE; TRAINING;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DICYCLOMINE; DRUG ADMINISTRATION SCHEDULE; ENVIRONMENT; FEAR; INHIBITION (PSYCHOLOGY); MALE; MUSCARINIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1;

EID: 33747855506     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2006.02.006     Document Type: Article

References (45)

1. Anagnostaras S.G., Maren S., and Fanselow M.S. Scopolamine selectively disrupts the acquisition of contextual fear conditioning in rats. Neurobiology of Learning and Memory 64 (1995) 191-194
2. Anagnostaras S.G., Maren S., Sage J.R., Goodrich S., and Fanselow M.S. Scopolamine and pavlovian fear conditioning in rats: Dose-effect analysis. Neuropsychopharmacology 21 6 (1999) 731-744
3. Anglade F., Bizot J.C., Dodd R.H., Baudoin C., and Chapouthier G. Opposite effects of cholinergic agents and benzodiazepine receptor ligands in a passive avoidance task in rats. Neuroscience Letters 182 (1994) 247-250
4. Bammer G. Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: A review and some new results. Neuroscience and Biobehavioral Reviews 6 (1982) 247-296
5. Baratti C.M., Huygens P., Mino J., Merlo A., and Gardella J. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice. Psychopharmacology 64 (1979) 85-88
6. Bartolini A., Ghelardini C., Fantetti L., Malcangio M., Malmberg-Aiello P., and Giotti A. Role of muscarinic receptor subtypes in central antinociception. British Journal of Pharmacology 105 (1992) 77-82
7. Bartus R.T., Dean R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-417
8. Calhoun W.H., and Smith A.A. Effects of scopolamine on acquisition of passive avoidance. Psychopharmacologia 13 (1968) 201-209
9. Caulfield M.P., Higgins G.A., and Straughan D.W. Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. Journal of Pharmacy and Pharmacology 35 (1983) 131-132
10. Cruz-Morales S.E., Duran-Arevalo M., Diaz Del Guante M.A., Quirarte G., and Prado-Alcala R.A. A threshold for the protective effect of over-reinforced passive avoidance against scopolamine-induced amnesia. Behavioral and Neural Biology 57 (1992) 256-259
11. Deutsch J.A. The cholinergic synapse and the site of memory. Science 174 (1971) 788-794
12. Doods H.N., Mathy M.J., Davidesko D., van Charldorp K.J., de Jonge A., and van Zwieten P.A. Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. Journal of pharmacology and experimental therapeutics 242 (1987) 257-262
13. Elrod K., and Buccafusco J.J. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmacology, Biochemistry, and Behavior 29 (1988) 15-21
14. Everitt J.B., and Robbins W.T. Central cholinegic systems and cognition. Annual Review of Psychology 48 (1997) 649-684
15. Feiro O., and Gould T.J. The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice. Pharmacology, Biochemistry, and Behavior 80 2 (2005) 251-262
16. Ferreira A.R., Furstenau L., Blanco C., Kornisiuk E., Sanchez G., Daroit D., et al. Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat. Pharmacology, Biochemistry, and Behavior 74 2 (2003) 411-415
17. Fibiger H.C., Damsma G., and Day J.C. Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. Advances in Experimental Medicine and Biology 295 (1991) 399-414
18. Fornari R.V., Moreira K.M., and Oliveira M.G.M. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learning and Memory 7 (2000) 287-292
19. 4 receptors in the mouse passive avoidance test. Journal of Pharmacology and Experimental Therapeutics 286 (1998) 1115-1121
20. Galeotti N., Ghelardini C., and Bartolini A. Role of 5-HT1A receptors in a mouse passive avoidance paradigm. Japanese Journal of Pharmacology 84 4 (2000) 418-424
21. Glick S.D., and Zimmerberg B. Amnesic effects of scopolamine. Behavioral biology 7 (1972) 245-254
22. Hagan J.J., Jansen J.H., and Broekkamp C.L. Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine. Psychopharmacology 93 (1987) 470-476
23. Hunter A.J., and Roberts F.F. The effect of pirenzepine on spatial learning in the Morris Water Maze. Pharmacology, Biochemistry, and Behavior 30 (1988) 519-523
24. Izquierdo I. Mechanism of action of scopolamine as an amnestic. Trends in Pharmacological Sciences 10 5 (1989) 175-177
25. Izquierdo I., Da Cunha C., Rosat R., Jerusalinsky D., Ferreira M.B., and Medina J.H. Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. Behavioral and Neural Biology 58 (1992) 16-26
26. Kimura Y., Ohue M., Kitaura T., and Kihira K. Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: Differences in binding properties to the brain muscarinic receptor. Brain Research 834 1-2 (1999) 6-12
27. Levey A.I., Kitt C., Simonds W., Price D., and Brann M.R. Identification and localization of muscarinic receptor subtype proteins in rat brain. The Journal of Neuroscience 11 10 (1991) 3218-3226
28. Maren S. What the amygdala does and doesn't do in aversive learning. Learning and Memory 10 (2003) 306-308
29. Meyers B. Some effects of scopolamine on a passive avoidance response in rats. Psychopharmacologia 8 (1965) 111-119
30. Moreira K.M., Hipolide D.C., Nóbrega J.N., Bueno O.F., Tufik S., and Oliveira M.G. Deficits in avoidance responding after paradoxical sleep deprivation are not associated with altered [3H]pirenzepine binding to M1 muscarinic receptors in rat brain. Brain Research 977 1 (2003) 31-37
31. Ohnuki T., and Nomura Y. Effects of selective muscarinic antagonists, pirenzepine and AF-DX 116, on passive avoidance tasks in mice. Biological and Pharmaceutical Bulletin 19 (1996) 814-818
32. Overton D.A. Dissociated learning in drugs states (state dependent learning). In: Efron D.H., Cole J.O., Levine J., and Wittenborn J.R. (Eds). Psychopharmacology: A review of progress 1957-1967 (1968), Public Health Service, Washington 918-930
33. Power A.E., McIntyre C.K., Litmanovich A., and McGaugh J.L. Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors. Behavioural Pharmacology 14 (2003) 207-213
34. Power A.E., Vazdarjanova A., and McGaugh J.L. Muscarinic cholinergic influences in memory consolidation. Neurobiology of Learning and Memory 80 3 (2003) 178-193
35. Roldán G., Bolaños-Badillo E., González-Sánchez H., Quirarte G.L., and Prado-Alcalá R.A. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats. Neuroscience Letters 230 (1997) 93-96
36. Roldan G., Cobos-Zapiain G., Quirarte G.L., and Prado-Alcala R.A. Dose- and time-dependent scopolamine-induced recovery of an inhibitory avoidance response after its extinction in rats. Behavioural Brain Research 121 1-2 (2001) 173-179
37. Rudy J.W. Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning. Neurobiology of Learning and Memory 65 (1996) 73-81
38. Rush D.K. Scopolamine amnesia of passive avoidance: A deficit of information acquisition. Behavioral and Neural Biology 50 (1988) 255-274
39. Sala M., Braida D., Calcaterra P., Leone M.P., Comotti F.A., Gianola S., et al. Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat. European Journal of Pharmacology 194 (1991) 45-49
40. Tinsley M.R., Quinn J.J., and Fanselow M.S. The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: comparing Pavlovian fear conditioning and inhibitory avoidance. Learning and Memory 11 (2004) 35-42
41. Van der Zee E.A., and Lutien P.G.M. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: A review of immunocytochemical localization in relation to learning and memory. Progress in Neurobiology 58 5 (1999) 409-471
42. Vazdarjanova A., and McGaugh J.L. Basolateral amygdala is involved in modulating consolidation of memory for classical fear conditioning. The Journal of Neuroscience 19 15 (1999) 6615-6622
43. Wallenstein G.V., and Vago D.R. Intrahippocampal scopolamine impairs both acquisition and consolidation of contextual fear conditioning. Neurobiology of Learning and Memory 75 (2001) 245-252
44. Wei J., Walton E.A., Milici A., and Buccafusco J.J. m1-m5 muscarinic receptor distribuition in rat CNS by RT-PCR and HPLC. Journal of Neurochemistry 63 (1994) 815-821
45. Worms P., Gueudet C., Perio A., and Soubrie P. Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats. Psychopharmacology 98 (1989) 286-288